Investors were caught by surprise on 11 July as Eli Lilly & Co. revealed that the president of its Bio-Medicines unit, Christi Shaw, is leaving at the end of August, with Patrick Jonsson, currently president and general manager of Lilly Japan, selected to succeed her. Shaw’s move wasn’t a mystery for long.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?